Programmed Death-1 - Globe Thesis

Keyword [Programmed Death-1] Result: 81 - 94 \| Page: 5 of 5
81.	Correlation Between The Expression Of PD-1/PD-L1 On NK Cells And HBV Infection
82.	Expression Of The Human PD-1 Extracellular Domain And Its Nanobody Screening
83.	Expression And Clinical Significance Of PD-1/PD-L1 In Children With Acute Lymphoblastic Leukemia
84.	The Role And Evaluation Of Anlotinib And PD-1 Inhibitors In Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Based On Interventional Therapy
85.	Expression Of TIM-3?PD-1 And EGFR In Non-small Cell Lung Cancer And Their Relationship With Clinical Characteristics And Prognosis
86.	Clinical Trial Of Programmed Death-1 Inhibitors Combined With Endostar And Cisplatin-based Chemotherapy In The First-line Treatment Of Advanced Squamous Cell Lung Cancer
87.	Clinical Characteristics And Related Analysis Of EGFR?ALK?ROS1 And PD-1/PD-L1 In Non-small Cell Lung Cancer
88.	Clinical Analysis Of PD-1 Receptor Inhibitor Combined With P-Gemox-Dex Regimen In The Primary Treatment Of Phase ?/? Extranodal Natural Killer/T Cell Lymphoma
89.	Systematic Review Of The Efficacy And Safety Of Immunotherapy Combined With Chemotherapy In The First-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma
90.	TGF-?1 Induces Immune Escape By Enhancing PD-1 And CTLA-4 Expression On T Lymphocytes In Hepatocellular Carcinoma
91.	Correlation Between SPD-1 In Peripheral Blood Of Patients With Hepatocellular Carcinoma And Detection Of PD-1 In Hepatocellular Carcinoma Specimens And Its Relationship With Prognosis
92.	Construction For Prognostic Assessment Of Triple-negative Breast Cancer,Expressions And Clinical Significance Of Immune Checkpoint-related Proteins
93.	Study On The Main Active Ingredients Of Platycodon Grandiflorum Trigger Anti-tumor Mechanism Through Immune Regulation
94.	Identification And Characterization Of Small Molecule Inhibitors Against PD-L1
<<First <Prev Next> Last>> Jump to